← SynDRA
IBANDRONIC ACID
SynDRA canonical compound SYN0003038 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | FDPS |
|---|
| Mechanism of action | bone resorption inhibitor |
|---|
| Indication | osteoporosis |
|---|
| Disease area | orthopedics |
|---|
All known targets
Mechanisms of action (all sources)
- FDPS INHIBITOR
- Farnesyl diphosphate synthase inhibitor
- bone resorption inhibitor
- FDPS MODULATOR
Drug classes
- Bisphosphonate
- Bone Density Conservation Agents
ATC classes
- M05B · DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Cross-references
Synonyms
- bonviva
- ibandronate
- boniva
- ibandronate sodium
- Acide ibandronique
- Acido ibandronico
- Bondenza
- Ibandronate
- NSC-722623
- BFQ
- Acid ibandronico
- Bisphosphonate 2
- R484
- RPR-102289A
- Bondronat (TN)
- Boniva (TN)
- Bonviva (TN)
- Ibandronic acid (INN)
- Ibandronic acid [INN:BAN]
- Ibandronic acid, sodium salt, monohydrate
- Roche brand of ibandronic acid, sodium salt, monohydrate
- [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid
- [1-HYDROXY-3-(METHYL-PENTYL-AMINO)-1-PHOSPHONO-PROPYL]-PHOSPHONIC ACID
- (1-Hydroxy-3-(methylpentylamino)propylidene)diphosphonic acid
- (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
- 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate
- ibandronic-acid
- Ibandronic Acid Teva
- Iasibon
- UMD7G2653W
- Ibandronic Acid Accord
- NSC 722623
- Ibandronic Acid Sandoz
- acide ibandronique
- Quodixor
- acidum ibandronicum
- RefChem:56785
Reported adverse events
- Osteonecrosis
- Headache
- Hypersensitivity
- Rash
- Arthralgia
- Dyspepsia
- Influenza
- Influenza like illness
- Myalgia
- Nausea
- Asthenia
- Dizziness
Look up IBANDRONIC ACID in the interactive SynDRA portal →